Clinical Trials
2 trialsNCT04316169 2022-12-23
Hydroxychloroquine, Abemaciclib and Endocrine Therapy in Hormone Receptor Positive (HR+)/Her 2 Negative Breast Cancer
Medical College of Wisconsin
Phase 1 Withdrawn
NCT03015324 2022-01-25
Biological Effects of Agent on PAR-4 Levels With Resected Solid Tumors
University of Kentucky
Phase 1 Completed